Opaleye Management reports $31,687 Grace Therapeutics common share purchase
GRCE•Opaleye Management increases Grace Therapeutics stake
Opaleye Management raised its stake in Grace Therapeutics to 2,855,318 shares, held indirectly through Opaleye, L.P.
The fund bought 15,089 shares at $2.10 each in open-market purchases.
